XML 56 R59.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION (Details 2) (USD $)
12 Months Ended
Oct. 30, 2011
Y
Oct. 31, 2010
Oct. 25, 2009
Oct. 30, 2011
Stock options
Y
Oct. 31, 2010
Stock options
Y
Oct. 25, 2009
Stock options
Y
Oct. 30, 2011
Nonvested shares
Oct. 31, 2010
Nonvested shares
Oct. 25, 2009
Nonvested shares
Stock-based compensation                  
Cash received from stock options exercised       $ 53,800,000 $ 22,900,000 $ 2,400,000      
Tax benefit realized from stock options, aggregate       20,800,000 18,900,000 1,300,000      
Reconciliation of Stock Options                  
Outstanding, at the beginning of the period (in shares)       22,048,000          
Granted (in shares)       2,658,000          
Exercised (in shares)       4,750,000          
Forfeited (in shares)       24,000          
Outstanding, at the end of the period (in shares)       19,932,000 22,048,000        
Exercisable at the end of the period (in shares)       13,499,000          
Weighted-Average Exercise Price                  
Outstanding at the beginning of the period (in dollars per share)       $ 16.47          
Granted (in dollars per share)       $ 24.96          
Exercised (in dollars per share)       $ 15.27          
Forfeitures (in dollars per share)       $ 19.11          
Outstanding at the end of the period (in dollars per share)       $ 17.89 $ 16.47        
Exercisable at end of period (in dollars per share)       $ 16.66          
Weighted-Average Remaining Contractual Term                  
Outstanding at the end of the period (in years)       5.7          
Exercisable at end of period (in years)       4.5          
Aggregate Intrinsic Value                  
Outstanding at the end of the period       240,451,000          
Exercisable at end of period       179,436,000          
Weighted-average grant date fair value of stock options granted, and the total intrinsic value of options exercised                  
Weighted average grant date fair value (in dollars per share)       $ 5.54 $ 4.55 $ 2.93      
Intrinsic value of exercised options       54,859,000 32,378,000 5,049,000      
Weighted-average assumptions used to calculate fair value of each ordinary option award                  
Risk free interest rate (as a percent)       2.90% 3.40% 3.20%      
Expected Dividend Rate (as a percent)       2.00% 2.20% 2.50%      
Expected stock price volatility rate (as a percent)       21.00% 22.00% 22.00%      
Expected option Term (in years)       8 8 8      
Reconciliation of the nonvested shares                  
Nonvested shares at the beginning of the period             206,000    
Nonvested shares granted in period             52,000    
Nonvested shares vested in period             (43,000)    
Nonvested shares at the end of the period             215,000 206,000  
Weighted-average grant date fair value and total fair value of nonvested shares granted and vested                  
Nonvested shares at the beginning of the period (in dollars per share)             $ 18.13    
Nonvested shares granted in period (in dollars per share)             $ 25.11 $ 19.56 $ 15.27
Nonvested shares vested in period (in dollars per share)             $ 17.43    
Nonvested shares at the end of the period (in dollars per share)             $ 19.94 $ 18.13  
Fair value of nonvested shares granted             1,299,000 978,000 865,000
Fair value of nonvested shares vested             751,000 664,000 204,000
Stock-based compensation expense, along with the related income tax benefit                  
Stock based compensation expense recognized 17,229,000 14,402,000 12,054,000            
Income tax benefit recognized (6,542,000) (5,510,000) (4,633,000)            
Stock based compensation expense, net of tax 10,687,000 8,892,000 7,421,000            
Stock-based compensation expense unrecognized $ 12,300,000                
Period for recognition of unrecognized stock-based compensation expense (in years) 2.6                
Number of shares available for future grants 32,600,000 35,300,000 38,000,000